Exact Mass: 363.064

Exact Mass Matches: 363.064

Found 216 metabolites which its exact mass value is equals to given mass value 363.064, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Dihydrochelirubine

15-methoxy-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-1(13),2,4(8),9,11,14,16,21-octaene

C21H17NO5 (363.1107)


Dihydrochelirubine is a benzophenanthridine alkaloid that is dihydrosanguinarine bearing a methoxy substituent at position 10. It has a role as a metabolite. It is functionally related to a dihydrosanguinarine. Dihydrochelirubine is a natural product found in Eschscholzia californica, Glaucium flavum, and other organisms with data available. A benzophenanthridine alkaloid that is dihydrosanguinarine bearing a methoxy substituent at position 10.

   

Flufenacet

N-(4-Fluorophenyl)-N-(1-methylethyl)-2-((5-(trifluoromethyl)-1,3,4-thiadiazol-2-yl)oxy)acetamide

C14H13F4N3O2S (363.0665)


CONFIDENCE standard compound; INTERNAL_ID 255; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9423; ORIGINAL_PRECURSOR_SCAN_NO 9420 CONFIDENCE standard compound; INTERNAL_ID 255; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9408; ORIGINAL_PRECURSOR_SCAN_NO 9406 CONFIDENCE standard compound; INTERNAL_ID 255; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9375; ORIGINAL_PRECURSOR_SCAN_NO 9373 CONFIDENCE standard compound; INTERNAL_ID 255; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9386; ORIGINAL_PRECURSOR_SCAN_NO 9384 CONFIDENCE standard compound; INTERNAL_ID 255; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9401; ORIGINAL_PRECURSOR_SCAN_NO 9399 CONFIDENCE standard compound; INTERNAL_ID 255; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9344; ORIGINAL_PRECURSOR_SCAN_NO 9342 CONFIDENCE standard compound; INTERNAL_ID 8396 CONFIDENCE standard compound; INTERNAL_ID 3800

   

Cefadroxil

(6R,7R)-7-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H17N3O5S (363.0889)


Cefadroxil is only found in individuals that have used or taken this drug. It is a long-acting, broad-spectrum, water-soluble, cephalexin derivative.Like all beta-lactam antibiotics, cefadroxil binds to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, causing the inhibition of the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that cefadroxil interferes with an autolysin inhibitor. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic CONFIDENCE standard compound; EAWAG_UCHEM_ID 3662

   

Guanosine monophosphate

{[(2R,3S,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

C10H14N5O8P (363.058)


Guanosine monophosphate (GMP), also known as 5′-guanidylic acid or guanylic acid (conjugate base guanylate), is a nucleotide that is used as a monomer in RNA. It is an ester of phosphoric acid with the nucleoside guanosine. GMP consists of the phosphate group, the pentose sugar ribose, and the nucleobase guanine; hence it is a ribonucleoside monophosphate. Guanosine monophosphate is commercially produced by microbial fermentation. Guanosine monophosphate, also known as guanylic acid or 5-GMP, belongs to the class of organic compounds known as purine ribonucleoside monophosphates. These are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached. A guanine nucleotide containing one phosphate group esterified to the sugar moiety and found widely in nature. Guanosine monophosphate exists in all living species, ranging from bacteria to humans. Within humans, guanosine monophosphate participates in a number of enzymatic reactions. In particular, guanosine triphosphate and guanosine monophosphate can be biosynthesized from diguanosine tetraphosphate through its interaction with the enzyme bis(5-nucleosyl)-tetraphosphatase [asymmetrical]. In addition, guanosine monophosphate can be biosynthesized from guanosine diphosphate; which is mediated by the enzyme ectonucleoside triphosphate diphosphohydrolase 5. In humans, guanosine monophosphate is involved in the metabolic disorder called the lesch-nyhan syndrome (lns) pathway. Outside of the human body, guanosine monophosphate has been detected, but not quantified in several different foods, such as common cabbages, tea, winter squash, spearmints, and sugar apples. Guanosine-5-monophosphate, also known as 5-gmp or guanylic acid, is a member of the class of compounds known as purine ribonucleoside monophosphates. Purine ribonucleoside monophosphates are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached. Guanosine-5-monophosphate is slightly soluble (in water) and a moderately acidic compound (based on its pKa). Guanosine-5-monophosphate can be found in a number of food items such as mustard spinach, swiss chard, watercress, and colorado pinyon, which makes guanosine-5-monophosphate a potential biomarker for the consumption of these food products. Guanosine-5-monophosphate can be found primarily in blood and saliva, as well as throughout most human tissues. Guanosine-5-monophosphate exists in all living species, ranging from bacteria to humans. In humans, guanosine-5-monophosphate is involved in several metabolic pathways, some of which include clarithromycin action pathway, erythromycin action pathway, minocycline action pathway, and tetracycline action pathway. Guanosine-5-monophosphate is also involved in several metabolic disorders, some of which include gout or kelley-seegmiller syndrome, xanthine dehydrogenase deficiency (xanthinuria), aICA-Ribosiduria, and molybdenum cofactor deficiency. Guanosine monophosphate is known as E number reference E626.[7] In the form of its salts, such as disodium guanylate (E627), dipotassium guanylate (E628) and calcium guanylate (E629), are food additives used as flavor enhancers to provide the umami taste.[7] It is often used in synergy with disodium inosinate; the combination is known as disodium 5′-ribonucleotides. Disodium guanylate is often found in instant noodles, potato chips and snacks, savoury rice, tinned vegetables, cured meats, and packet soup. As it is a fairly expensive additive, it is usually not used independently of glutamic acid or monosodium glutamate (MSG), which also contribute umami. If inosinate and guanylate salts are present in a list of ingredients but MSG does not appear to be, the glutamic acid is likely provided as part of another ingredient, such as a processed soy protein complex (hydrolyzed soy protein), autolyzed yeast, or soy sauce. 5'-Guanylic acid (5'-GMP) is involved in several metabolic disorders, including the AICA-ribosiduria pathway, adenosine deaminase deficiency, adenine phosphoribosyltransferase deficiency (aprt), and the 2-hydroxyglutric aciduria pathway. 5'-Guanylic acid (5'-GMP) is involved in several metabolic disorders, including the AICA-ribosiduria pathway, adenosine deaminase deficiency, adenine phosphoribosyltransferase deficiency (aprt), and the 2-hydroxyglutric aciduria pathway.

   

Rufloxacin

7-fluoro-6-(4-methylpiperazin-1-yl)-10-oxo-4-thia-1-azatricyclo[7.3.1.0⁵,¹³]trideca-5(13),6,8,11-tetraene-11-carboxylic acid

C17H18FN3O3S (363.1053)


Rufloxacin belongs to the family of Phenylpiperazines. These are compounds containing a phenylpiperazine skeleton, which consists of a piperazine bound to a phenyl group. J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors Same as: D02474

   

Guanosine 3'-monophosphate

{[(2R,3S,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}phosphonic acid

C10H14N5O8P (363.058)


Guanosine 3-monophosphate, also known as 3-GMP or 3-guanylic acid, belongs to the class of organic compounds known as purine nucleosides. Purine nucleosides are compounds comprising a purine base attached to a ribosyl or deoxyribosyl moiety. Guanosine 3-monophosphate has been identified in the human placenta (PMID: 32033212).

   

Oxychelerythrine

(1,3)Benzodioxolo(5,6-c)phenanthridin-13(12H)-one, 1,2-dimethoxy-12-methyl- (9CI)

C21H17NO5 (363.1107)


   

Cyclic pyranopterin monophosphate

(4aR,5aR,11aR,12aS)-2,10,12,12-tetrahydroxy-8-imino-4,4a,5a,6,7,8,11,11a,12,12a-decahydro-2H-1,3,5-trioxa-6,7,9,11-tetraaza-2lambda5-phosphatetracen-2-one

C10H14N5O8P (363.058)


Cyclic pyranopterin monophosphate, also known as cpmp or precursor z, hydrated, belongs to pyranopterins and derivatives class of compounds. Those are pterin derivatives in which a pyran ring is fused either to the pyrimidine ring or the pyrazine ring of the pterin moiety. Cyclic pyranopterin monophosphate is slightly soluble (in water) and an extremely strong acidic compound (based on its pKa). Cyclic pyranopterin monophosphate can be found in a number of food items such as european cranberry, vaccinium (blueberry, cranberry, huckleberry), peanut, and dill, which makes cyclic pyranopterin monophosphate a potential biomarker for the consumption of these food products. Cyclic pyranopterin monophosphate exists in all living organisms, ranging from bacteria to humans. Cyclic pyranopterin monophosphate (cPMP) is an experimental treatment for molybdenum cofactor deficiency type A, which was developed by José Santamaría-Araujo and Guenter Schwarz at the German universities TU Braunschweig and the University of Cologne . A - Alimentary tract and metabolism > A16 - Other alimentary tract and metabolism products > A16A - Other alimentary tract and metabolism products > A16AX - Various alimentary tract and metabolism products Cyclic pyranopterin monophosphate is part of the Cofactor biosynthesis, Folate biosynthesis, and Sulfur relay system pathways. It is a substrate for: Molybdopterin synthase catalytic subunit. C78272 - Agent Affecting Nervous System

   

Benzoximate

Pesticide4_Benzoximate_C18H18ClNO5_Methanone, (benzoyloxy)(3-chloro-2,6-dimethoxyphenyl)-, O-ethyloxime, (Z)-

C18H18ClNO5 (363.0873)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007096 - Imidoesters

   

8-Hydroxy-5-deazaflavin

7,8-Didemethyl-8-hydroxy-5-deazariboflavin

C16H17N3O7 (363.1066)


   

8-Oxo-dGMP

{[(3S)-5-(2-amino-6,8-dioxo-6,7,8,9-tetrahydro-3H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy}phosphonic acid

C10H14N5O8P (363.058)


8-Oxo-dGMP is a metabolite of 8-oxo-dGTP. 8-Oxo-7,8-dihydro-2-deoxyguanosine 5-triphosphate (8-oxo-dGTP) is a potent mutagenic substrate for DNA synthesis. 8-Oxo-dGTP is rapidly degraded to 8-oxo-dGMP by cellular 8-oxo-dGTPase activity. 8-Oxo-dGMP is further degraded to 8-oxo-deoxyguanosine by a nucleotidase. 8-Oxo-dGMP is the most preferred substrate of this nucleotidase enzyme (PMID: 7819228). The human MutT homologue (hMTH1), an 8-oxo-dGTPase, prevents misincorporation of 8-oxo-dGTP into DNA by hydrolyzing it to 8-oxo-dGMP. hMTH1 mRNA is overexpressed in human renal cell carcinomas and breast tumors. Likewise, elevated levels of hMTH1 protein have also been detected in brain tumors. (PMID: 12757855) [HMDB] 8-Oxo-dGMP is a metabolite of 8-oxo-dGTP. 8-Oxo-7,8-dihydro-2-deoxyguanosine 5-triphosphate (8-oxo-dGTP) is a potent mutagenic substrate for DNA synthesis. 8-Oxo-dGTP is rapidly degraded to 8-oxo-dGMP by cellular 8-oxo-dGTPase activity. 8-Oxo-dGMP is further degraded to 8-oxo-deoxyguanosine by a nucleotidase. 8-Oxo-dGMP is the most preferred substrate of this nucleotidase enzyme (PMID: 7819228). The human MutT homologue (hMTH1), an 8-oxo-dGTPase, prevents misincorporation of 8-oxo-dGTP into DNA by hydrolyzing it to 8-oxo-dGMP. hMTH1 mRNA is overexpressed in human renal cell carcinomas and breast tumors. Likewise, elevated levels of hMTH1 protein have also been detected in brain tumors. (PMID: 12757855).

   

Guanosine 2'-monophosphate

{[(2R,3R,4R,5R)-2-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-4-hydroxy-5-(hydroxymethyl)oxolan-3-yl]oxy}phosphonic acid

C10H14N5O8P (363.058)


Guanosine 2-monophosphate, also known as 2-GMP or 2-O-phosphoguanosine, belongs to the class of organic compounds known as pentose phosphates. These are carbohydrate derivatives containing a pentose substituted by one or more phosphate groups. Guanosine 2-monophosphate is a purine ribonucleoside 2-monophosphate having guanine as the nucleobase.

   

7-Methyl-2'-deoxyguanosine-3'-monophosphate

{[5-(6-hydroxy-2-imino-7-methyl-3,7,8,9-tetrahydro-2H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-yl]oxy}phosphonate

C11H18N5O7P (363.0944)


   

Adenosine 5'-phosphorothioate

{[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonothioic acid

C10H14N5O6PS (363.0402)


   

Etofibrate

2-(Pyridine-3-carbonyloxy)ethyl 2-(4-chlorophenoxy)-2-methylpropanoic acid

C18H18ClNO5 (363.0873)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AB - Fibrates D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D009676 - Noxae > D000963 - Antimetabolites

   

7-(2-Chloro-6-fluorophenyl)-5-(4-chlorophenyl)-1,5,6,7-tetrahydrotetrazolo[1,5-a]pyrimidine

7-(2-chloro-6-fluorophenyl)-5-(4-chlorophenyl)-4H,5H,6H,7H-[1,2,3,4]tetrazolo[1,5-a]pyrimidine

C16H12Cl2FN5 (363.0454)


   

[(2R,5R)-5-(2-Amino-6-oxo-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

{[3,4-dihydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2H-purin-9-yl)oxolan-2-yl]methoxy}phosphonic acid

C10H14N5O8P (363.058)


Widely distributed in plants and animals, occurs in the hydrolysates of RNA

   

3-(1,3-Benzodioxol-5-ylmethoxy)-1-chloro-4-(4-fluorophenyl)piperidine

3-[(2H-1,3-benzodioxol-5-yl)methoxy]-1-chloro-4-(4-fluorophenyl)piperidine

C19H19ClFNO3 (363.1037)


   

4'-(9-Acridinylamino)methanesulfonanilide

N-{4-[(9,10-dihydroacridin-9-ylidene)amino]phenyl}methanesulphonamide

C20H17N3O2S (363.1041)


   

2-Hydroxyethyl glucosinolate

{[(Z)-(3-hydroxy-1-{[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulphanyl}propylidene)amino]oxy}sulphonic acid

C9H17NO10S2 (363.0294)


2-hydroxyethyl glucosinolate is a member of the class of compounds known as alkylglucosinolates. Alkylglucosinolates are organic compounds containing a glucosinolate moiety that carries an alkyl chain. 2-hydroxyethyl glucosinolate is soluble (in water) and an extremely strong acidic compound (based on its pKa). 2-hydroxyethyl glucosinolate can be found in capers, which makes 2-hydroxyethyl glucosinolate a potential biomarker for the consumption of this food product.

   

6-Methoxydihydrosanguinarine

23-methoxy-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaene

C21H17NO5 (363.1107)


   
   
   
   

Factor F0

7,8-Didemethyl-8-hydroxy-5-deazariboflavin

C16H17N3O7 (363.1066)


   

Turraeanthin B

11-Demethoxyl-12-methoxyl oxynitidine

C21H17NO5 (363.1107)


   

2-Hydroxyethyl glucosinolate

2-Hydroxyethyl glucosinolate

C9H17NO10S2 (363.0294)


   
   
   
   

FLAMPROP-ISOPROPYL

FLAMPROP-ISOPROPYL

C19H19ClFNO3 (363.1037)


CONFIDENCE standard compound; INTERNAL_ID 357; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9643; ORIGINAL_PRECURSOR_SCAN_NO 9642 CONFIDENCE standard compound; INTERNAL_ID 357; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9675; ORIGINAL_PRECURSOR_SCAN_NO 9673 CONFIDENCE standard compound; INTERNAL_ID 357; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9699; ORIGINAL_PRECURSOR_SCAN_NO 9697 CONFIDENCE standard compound; INTERNAL_ID 357; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9719; ORIGINAL_PRECURSOR_SCAN_NO 9718 CONFIDENCE standard compound; INTERNAL_ID 357; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9686; ORIGINAL_PRECURSOR_SCAN_NO 9684 DATASET 20200303_ENTACT_RP_MIX505; CONFIDENCE standard compound; INTERNAL_ID 357; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9686; ORIGINAL_PRECURSOR_SCAN_NO 9684 CONFIDENCE standard compound; INTERNAL_ID 357; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 9727; ORIGINAL_PRECURSOR_SCAN_NO 9726

   
   
   
   
   
   
   
   
   
   
   

CHEMBL3706542

CHEMBL3706542

C13H21N3O7S (363.11)


   

2,3,7,8-bismethylenedioxy-11-methoxy-5-methyl-5,6-dihydrodibenzophenanthridine|6-methoxy-13-methyl-13,14-dihydro-[1,3]dioxolo[4,5-i][1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridine|6-methoxydihydrosanguinarine|Dihydrochelirubin|dihydrochelirubine|O-methyl-11,12,13,14-tetradehydro-chelidonine

2,3,7,8-bismethylenedioxy-11-methoxy-5-methyl-5,6-dihydrodibenzophenanthridine|6-methoxy-13-methyl-13,14-dihydro-[1,3]dioxolo[4,5-i][1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridine|6-methoxydihydrosanguinarine|Dihydrochelirubin|dihydrochelirubine|O-methyl-11,12,13,14-tetradehydro-chelidonine

C21H17NO5 (363.1107)


   
   
   

(13-methyl-13,14-dihydro-[1,3]dioxolo[4,5-i][1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-6-yl)-methanol|6-hydroxymethyl-dihydro-sanguinarine|8-hydroxymethyl dihydrosanguinarine|8-Hydroxymethyldihydrosanguinarine

(13-methyl-13,14-dihydro-[1,3]dioxolo[4,5-i][1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-6-yl)-methanol|6-hydroxymethyl-dihydro-sanguinarine|8-hydroxymethyl dihydrosanguinarine|8-Hydroxymethyldihydrosanguinarine

C21H17NO5 (363.1107)


   
   

(-)-7-bromohomotrypargine

(-)-7-bromohomotrypargine

C16H22BrN5 (363.1058)


A natural product found in Pseudodistoma opacum.

   

8-methoxydihydrosanguinarine

8-methoxydihydrosanguinarine

C21H17NO5 (363.1107)


   

13-carboxaldehyde-8-oxocoptisine

13-carboxaldehyde-8-oxocoptisine

C20H13NO6 (363.0743)


   

6-methoxydihydrosanguinarine|dihydromacarpine

6-methoxydihydrosanguinarine|dihydromacarpine

C21H17NO5 (363.1107)


   

alpha-Hydroxyorcein

alpha-Hydroxyorcein

C21H17NO5 (363.1107)


A member of the class of phenoxazines that is 1,9-dimethyl-3H-phenoxazin-3-one carrying additional hydroxy and 2,4-dihydroxy-6-methylphenyl substituents at positions 7 and 8 respectively. A component of orcein, a mixture of dyes isolated from lichens.

   

Griseolic acid B

Griseolic acid B

C14H13N5O7 (363.0815)


   
   

6-Methoxydihydroavicine

11-methoxy-12-methyl-5,7,17,19-tetraoxa-12-azahexacyclo[11.11.0.02,10.04,8.014,22.016,20]tetracosa-1(13),2,4(8),9,14,16(20),21,23-octaene

C21H17NO5 (363.1107)


6-Methoxy Dihydrosanguinarine is a natural product found in Corydalis balansae and Chelidonium majus with data available.

   

Flufenacet

Pesticide5_Flufenacet_C14H13F4N3O2S_4-Fluoro-N-isopropyl-2-(5-trifluoromethyl-1,3,4-thiadiazol-2-yloxy)acetanilide

C14H13F4N3O2S (363.0665)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 709

   

Guanosine monophosphate

Guanosine-5-monophosphate disodium salt hydrate from Yeast

C10H14N5O8P (363.058)


COVID info from COVID-19 Disease Map, PDB, Protein Data Bank Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS relative retention time with respect to 9-anthracene Carboxylic Acid is 0.057 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.058 5'-Guanylic acid (5'-GMP) is involved in several metabolic disorders, including the AICA-ribosiduria pathway, adenosine deaminase deficiency, adenine phosphoribosyltransferase deficiency (aprt), and the 2-hydroxyglutric aciduria pathway. 5'-Guanylic acid (5'-GMP) is involved in several metabolic disorders, including the AICA-ribosiduria pathway, adenosine deaminase deficiency, adenine phosphoribosyltransferase deficiency (aprt), and the 2-hydroxyglutric aciduria pathway.

   

Guanosine 5-monophosphate

Guanosine 5-monophosphate

C10H14N5O8P (363.058)


A purine ribonucleoside 5-monophosphate having guanine as the nucleobase.

   

Rufloxacin

Rufloxacin

C17H18FN3O3S (363.1053)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01M - Quinolone antibacterials > J01MA - Fluoroquinolones D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D024841 - Fluoroquinolones C254 - Anti-Infective Agent > C258 - Antibiotic > C795 - Quinolone Antibiotic D004791 - Enzyme Inhibitors Same as: D02474

   

Guanosine-5-monophosphate

Guanosine-5-monophosphate

C10H14N5O8P (363.058)


   
   

L-gamma-Glutamyl-S-3-(1-oxopropyl)-L-cysteinyl-glycine

L-gamma-Glutamyl-S-3-(1-oxopropyl)-L-cysteinyl-glycine

C13H21N3O7S (363.11)


This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 16HP2005 to the Mass Spectrometry Society of Japan.

   

topramezone

topramezone

C16H17N3O5S (363.0889)


CONFIDENCE standard compound; INTERNAL_ID 460; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3178; ORIGINAL_PRECURSOR_SCAN_NO 3177 CONFIDENCE standard compound; INTERNAL_ID 460; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3195; ORIGINAL_PRECURSOR_SCAN_NO 3193 CONFIDENCE standard compound; INTERNAL_ID 460; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3168; ORIGINAL_PRECURSOR_SCAN_NO 3166 CONFIDENCE standard compound; INTERNAL_ID 460; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3180; ORIGINAL_PRECURSOR_SCAN_NO 3179 CONFIDENCE standard compound; INTERNAL_ID 460; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3178; ORIGINAL_PRECURSOR_SCAN_NO 3176 CONFIDENCE standard compound; INTERNAL_ID 460; DATASET 20200303_ENTACT_RP_MIX506; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 3179; ORIGINAL_PRECURSOR_SCAN_NO 3177

   
   
   

Broperamole

Broperamole

C15H18BrN5O (363.0695)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic

   

aristolochic acid sodium salt

aristolochic acid sodium salt

C17H10NNaO7 (363.0355)


   

Cefuroxime impurity H

Cefuroxime impurity H

C15H13N3O6S (363.0525)


   

5-NITRO-2-(4-NITROPHENYL)BENZANILIDE

5-NITRO-2-(4-NITROPHENYL)BENZANILIDE

C19H13N3O5 (363.0855)


   

1-(3-Bromo-pyridine-2-yl)-3-(3-ethoxycarbonyl-phenyl)-urea

1-(3-Bromo-pyridine-2-yl)-3-(3-ethoxycarbonyl-phenyl)-urea

C15H14BrN3O3 (363.0218)


   

(S)-tert-butyl 2-(5-iodo-1H-imidazol-2-yl)pyrrolidine-1-carboxylate

(S)-tert-butyl 2-(5-iodo-1H-imidazol-2-yl)pyrrolidine-1-carboxylate

C12H18IN3O2 (363.0444)


   

Thiazolidine, 3-[(4-ethoxyphenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)

Thiazolidine, 3-[(4-ethoxyphenyl)sulfonyl]-2-(4-methylphenyl)- (9CI)

C18H21NO3S2 (363.0963)


   

LOXITANE C

Loxapine hydrochloride

C18H19Cl2N3O (363.0905)


D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66885 - Serotonin Antagonist C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist

   

tert-Butyl 6-bromospiro[indene-1,4-piperidine]-1-carboxylate

tert-Butyl 6-bromospiro[indene-1,4-piperidine]-1-carboxylate

C18H22BrNO2 (363.0834)


   

2-amino-6-(3-chlorophenyl)-5-methyl-3-nitro-4-phenylbenzonitrile

2-amino-6-(3-chlorophenyl)-5-methyl-3-nitro-4-phenylbenzonitrile

C20H14ClN3O2 (363.0774)


   

L 701324

7-chloro-4-hydroxy-3-(3-phenoxyphenyl)quinolin-2(1H)-one

C21H14ClNO3 (363.0662)


D018377 - Neurotransmitter Agents > D018683 - Excitatory Amino Acid Agents > D018691 - Excitatory Amino Acid Antagonists D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D000928 - Antidepressive Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants D002491 - Central Nervous System Agents > D000927 - Anticonvulsants L-701324 is a potent, orally active NMDA receptor antagonist that antagonizes the activity of the NMDA receptor by blocking its glycine B binding site. L-701324 binds with high affinity to rat brain membranes (IC50=2 nM). L-701324 has antidepressant activity[1][2][3].

   

1-(4-chloro-3-nitrophenyl)-2,3,4,9-tetrahydro-1H-beta-carboline hydrochloride

1-(4-chloro-3-nitrophenyl)-2,3,4,9-tetrahydro-1H-beta-carboline hydrochloride

C17H15Cl2N3O2 (363.0541)


   

3-[(2S)-1-methyl-3,4-dihydro-2H-pyrrol-1-ium-2-yl]pyridine,perchloric acid,perchlorate

3-[(2S)-1-methyl-3,4-dihydro-2H-pyrrol-1-ium-2-yl]pyridine,perchloric acid,perchlorate

C10H15Cl2DN2O8 (363.0346)


   

5-chloro-3-(3,5-dimethylphenyl)sulfonyl-1H-indole-2-carboxylic acid

5-chloro-3-(3,5-dimethylphenyl)sulfonyl-1H-indole-2-carboxylic acid

C17H14ClNO4S (363.0332)


   

N-(2,5-Dimethoxyphenyl)-2-hydroxydibenzofuran-3-carboxamide

N-(2,5-Dimethoxyphenyl)-2-hydroxydibenzofuran-3-carboxamide

C21H17NO5 (363.1107)


   

Celestine blue

C.I. Mordant Blue 14 (8CI)

C17H18ClN3O4 (363.0986)


   
   

9,9-SPIROBIFLUORENE

9,9-SPIROBIFLUORENE

C18H18ClNO3S (363.0696)


   

3H-Xanthen-3-one,9-[4-(dimethylamino)phenyl]-2,6,7-trihydroxy-

3H-Xanthen-3-one,9-[4-(dimethylamino)phenyl]-2,6,7-trihydroxy-

C21H17NO5 (363.1107)


   

4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophene-7-carbaldehyde

4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]-1-benzothiophene-7-carbaldehyde

C21H17NO3S (363.0929)


   

Methacrylic acid, 2-hydroxyethyl ester diphenyl phosphate

Methacrylic acid, 2-hydroxyethyl ester diphenyl phosphate

C18H20O6P (363.0997)


   

2-(2-ETHOXY-1-PROPENYL)-3-(2-HYDROXYETHYL)BENZOTHIAZOLIUM PERCHLORATE

2-(2-ETHOXY-1-PROPENYL)-3-(2-HYDROXYETHYL)BENZOTHIAZOLIUM PERCHLORATE

C14H18ClNO6S (363.0543)


   

4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]benzenesulfonyl chloride

4-[(5-methyl-2-phenyl-1,3-oxazol-4-yl)methoxy]benzenesulfonyl chloride

C17H14ClNO4S (363.0332)


   

tert-butyl N-[2-hydroxy-2-(4-iodophenyl)ethyl]carbamate

tert-butyl N-[2-hydroxy-2-(4-iodophenyl)ethyl]carbamate

C13H18INO3 (363.0331)


   
   

Trimethyl[2-[(trimethylsilyl)methyl]benzyl]ammonium Iodide

Trimethyl[2-[(trimethylsilyl)methyl]benzyl]ammonium Iodide

C14H26INSi (363.0879)


   

Methyl 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carb oxylate

Methyl 5-[(3-chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-carb oxylate

C20H14ClN3O2 (363.0774)


   

Methyl 4-[3-(dimethylamino)propoxy]-3-iodobenzoate

Methyl 4-[3-(dimethylamino)propoxy]-3-iodobenzoate

C13H18INO3 (363.0331)


   

isopropyl N-benzoyl-N-(3-chloro-4-fluorophenyl)-L-alaninate

isopropyl N-benzoyl-N-(3-chloro-4-fluorophenyl)-L-alaninate

C19H19ClFNO3 (363.1037)


   

(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-2,10,11-triol,hydrobromide

(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-2,10,11-triol,hydrobromide

C17H18BrNO3 (363.047)


   

1-(3-bromo-4-hydroxyphenyl)-6-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol

1-(3-bromo-4-hydroxyphenyl)-6-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol

C17H18BrNO3 (363.047)


   

6,7-DIHYDRO-2-PENTAFLUOROPHENYL-5H-PYRROLO(2,1-C)-1,2,4-TRIAZOLIUM TETRAFLUOROBORATE

6,7-DIHYDRO-2-PENTAFLUOROPHENYL-5H-PYRROLO(2,1-C)-1,2,4-TRIAZOLIUM TETRAFLUOROBORATE

C11H7BF9N3 (363.0589)


   

2-Bromo-9,10-dihydro-9,9-dimethyl-10-phenylacridine

2-Bromo-9,10-dihydro-9,9-dimethyl-10-phenylacridine

C21H18BrN (363.0623)


   

3,5-Dichloro-N-[(1,1-dimethylethoxy)carbonyl]-L-tyrosine methyl ester

3,5-Dichloro-N-[(1,1-dimethylethoxy)carbonyl]-L-tyrosine methyl ester

C15H19Cl2NO5 (363.064)


   

9-DICYANOMETHYLENE-2,4,7-TRINITROFLUORENE

9-DICYANOMETHYLENE-2,4,7-TRINITROFLUORENE

C16H5N5O6 (363.024)


   

2-Hydroxy Cephalexin

2-Hydroxy Cephalexin

C16H17N3O5S (363.0889)


   

Dimethylaminophenylfluorone

Dimethylaminophenylfluorone

C21H17NO5 (363.1107)


   

2-bromo-7,7-dimethyl-5,7-dihydroindeno[2,1-b]carbazole

2-bromo-7,7-dimethyl-5,7-dihydroindeno[2,1-b]carbazole

C21H18BrN (363.0623)


   

7,8-diethoxy-4-oxo-4H-benzo[4,5]thiazolo[3,2-a]pyrimidine-3-carboxylic acid ethyl ester

7,8-diethoxy-4-oxo-4H-benzo[4,5]thiazolo[3,2-a]pyrimidine-3-carboxylic acid ethyl ester

C16H17N3O5S (363.0889)


   

Cephalexin Sulfoxide

Cephalexin Sulfoxide

C16H17N3O5S (363.0889)


   

Vonoprazan Impurity 3

Vonoprazan Impurity 3

C17H15F2N3O2S (363.0853)


   

N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine

N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine

C21H18BrN (363.0623)


   
   

H7

1-(5-Isoquinolinesulfonyl)-2-methylpiperazine dihydrochloride

C14H19Cl2N3O2S (363.0575)


   

[[(1R)-2-(6-aMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]-, Monophenylester

[[(1R)-2-(6-aMino-9H-purin-9-yl)-1-Methylethoxy]Methyl]-, Monophenylester

C15H18N5O4P (363.1096)


   

Chloro(cyclooctatetraenyl)(pentamethylcyclopentadienyl)zirconium(IV)

Chloro(cyclooctatetraenyl)(pentamethylcyclopentadienyl)zirconium(IV)

C18H22ClZr+ (363.0457)


   

Zacopride HCl

Zacopride HCl

C15H23Cl2N3O3 (363.1116)


C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent C78272 - Agent Affecting Nervous System > C267 - Antiemetic Agent

   

4-(9-Acridinylamino)methanesulfonanilide

4-(9-Acridinylamino)methanesulfonanilide

C20H17N3O2S (363.1041)


   

(3-Chloro-2,6-dimethoxyphenyl)(ethoxyimino)methyl benzoate

(3-Chloro-2,6-dimethoxyphenyl)(ethoxyimino)methyl benzoate

C18H18ClNO5 (363.0873)


D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D007096 - Imidoesters

   

N-(4-chloroanilino)-N-(4-chlorophenyl)-3,3-dimethyl-2-oxobutanimidamide

N-(4-chloroanilino)-N-(4-chlorophenyl)-3,3-dimethyl-2-oxobutanimidamide

C18H19Cl2N3O (363.0905)


   
   
   

4-(6-iodoimidazo[1,2-a]pyridin-2-yl)-N,N-dimethylaniline

4-(6-iodoimidazo[1,2-a]pyridin-2-yl)-N,N-dimethylaniline

C15H14IN3 (363.0232)


   

2-[(4-Phenylphenyl)sulfonylamino]pentanedioic acid

2-[(4-Phenylphenyl)sulfonylamino]pentanedioic acid

C17H17NO6S (363.0777)


   

5-bromo-N-[4-(4-methyl-1-piperazinyl)phenyl]-2-furancarboxamide

5-bromo-N-[4-(4-methyl-1-piperazinyl)phenyl]-2-furancarboxamide

C16H18BrN3O2 (363.0582)


   

(6R,7R)-7-[[2-amino-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6R,7R)-7-[[2-amino-2-(4-hydroxyphenyl)-1-oxoethyl]amino]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H17N3O5S (363.0889)


   
   
   

4-Chloro-1-naphthyl 5-methoxy-2-(2-pyridinyl)-4-pyrimidinyl ether

4-Chloro-1-naphthyl 5-methoxy-2-(2-pyridinyl)-4-pyrimidinyl ether

C20H14ClN3O2 (363.0774)


   

2,5-dichloro-N-[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]benzamide

2,5-dichloro-N-[5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]benzamide

C16H11Cl2N3O3 (363.0177)


   

S-[5-(Trifluoromethyl)-4H-1,2,4-triazol-3-YL] 5-(phenylethynyl)furan-2-carbothioate

S-[5-(Trifluoromethyl)-4H-1,2,4-triazol-3-YL] 5-(phenylethynyl)furan-2-carbothioate

C16H8F3N3O2S (363.0289)


   

4-{5-[(1z)-1-(2-Imino-4-Oxo-1,3-Thiazolidin-5-Ylidene)ethyl]-2-Furyl}benzenesulfonamide

4-{5-[(1z)-1-(2-Imino-4-Oxo-1,3-Thiazolidin-5-Ylidene)ethyl]-2-Furyl}benzenesulfonamide

C15H13N3O4S2 (363.0347)


   

4-{5-[(Z)-(2-Imino-4-Oxo-1,3-Thiazolidin-5-Ylidene)methyl]-2-Furyl}-N-Methylbenzenesulfonamide

4-{5-[(Z)-(2-Imino-4-Oxo-1,3-Thiazolidin-5-Ylidene)methyl]-2-Furyl}-N-Methylbenzenesulfonamide

C15H13N3O4S2 (363.0347)


   

N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine

N-(dibenzo[b,d]thiophen-3-ylsulfonyl)-L-valine

C17H17NO4S2 (363.0599)


   

[n-(Benzyloxycarbonyl)amino](4-amidinophenyl)methane-phosphonate

[n-(Benzyloxycarbonyl)amino](4-amidinophenyl)methane-phosphonate

C16H18N3O5P (363.0984)


   

(6,7-Dihydro-5H-cyclopenta[D]imidazo[2,1-B]thiazol-2-YL]-4,7-dihydro[1,4]thiazepine-3,6-dicarboxylic acid

(6,7-Dihydro-5H-cyclopenta[D]imidazo[2,1-B]thiazol-2-YL]-4,7-dihydro[1,4]thiazepine-3,6-dicarboxylic acid

C15H13N3O4S2 (363.0347)


   

Etofibrate

Etofibrate

C18H18ClNO5 (363.0873)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent C - Cardiovascular system > C10 - Lipid modifying agents > C10A - Lipid modifying agents, plain > C10AB - Fibrates D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D009676 - Noxae > D000963 - Antimetabolites

   

5-Amino-11,11,14-trihydroxy-14-oxo-13,15,18-trioxa-2,4,6,9-tetraza-14lambda5-phosphatetracyclo[8.8.0.03,8.012,17]octadeca-3(8),5-dien-7-one

5-Amino-11,11,14-trihydroxy-14-oxo-13,15,18-trioxa-2,4,6,9-tetraza-14lambda5-phosphatetracyclo[8.8.0.03,8.012,17]octadeca-3(8),5-dien-7-one

C10H14N5O8P (363.058)


   

[5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen sulate

[5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl hydrogen sulate

C10H13N5O8S (363.0485)


   

S-3-oxopropylglutathione

S-3-oxopropylglutathione

C13H21N3O7S (363.11)


   

Adenosine 5-phosphorothioate

Adenosine 5-phosphorothioate

C10H14N5O6PS (363.0402)


   
   

S-(acet-2-yl)-glutathione

S-(acet-2-yl)-glutathione

C12H17N3O8S-2 (363.0736)


   

N-(4,6-dimethylpyrimidin-2-yl)-N-(2-methoxycarbonylphenyl)sulfonylcarbamimidate

N-(4,6-dimethylpyrimidin-2-yl)-N-(2-methoxycarbonylphenyl)sulfonylcarbamimidate

C15H15N4O5S- (363.0763)


   

[(3S)-5-(2-amino-6,8-dioxo-1,7-dihydropurin-9-yl)-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate

[(3S)-5-(2-amino-6,8-dioxo-1,7-dihydropurin-9-yl)-3-hydroxyoxolan-2-yl]methyl dihydrogen phosphate

C10H14N5O8P (363.058)


   

2-(6-Aminopurin-9-yl)-5-(dihydroxyphosphinothioyloxymethyl)oxolane-3,4-diol

2-(6-Aminopurin-9-yl)-5-(dihydroxyphosphinothioyloxymethyl)oxolane-3,4-diol

C10H14N5O6PS (363.0402)


   

Isoguanosine 5-monophosphate

Isoguanosine 5-monophosphate

C10H14N5O8P (363.058)


   

3-Bromo-N-[2-(4-nitroanilino)ethyl]benzamide

3-Bromo-N-[2-(4-nitroanilino)ethyl]benzamide

C15H14BrN3O3 (363.0218)


   

5-Carbamoyl-4-methyl-2-[[(3-nitrophenyl)-oxomethyl]amino]-3-thiophenecarboxylic acid methyl ester

5-Carbamoyl-4-methyl-2-[[(3-nitrophenyl)-oxomethyl]amino]-3-thiophenecarboxylic acid methyl ester

C15H13N3O6S (363.0525)


   

2-[(2-methyl-4-benzofuro[3,2-d]pyrimidinyl)thio]-N-(phenylmethyl)acetamide

2-[(2-methyl-4-benzofuro[3,2-d]pyrimidinyl)thio]-N-(phenylmethyl)acetamide

C20H17N3O2S (363.1041)


   

5-(4-Chlorophenyl)-2-(4-methoxyphenyl)sulfonyl-3-pyrazolamine

5-(4-Chlorophenyl)-2-(4-methoxyphenyl)sulfonyl-3-pyrazolamine

C16H14ClN3O3S (363.0444)


   

10-(4-methoxyphenyl)-2-methyl-8,9-dihydro-3H-cyclopenta[5,6]pyrido[3,2:4,5]thieno[3,2-d]pyrimidin-4(7H)-one

10-(4-methoxyphenyl)-2-methyl-8,9-dihydro-3H-cyclopenta[5,6]pyrido[3,2:4,5]thieno[3,2-d]pyrimidin-4(7H)-one

C20H17N3O2S (363.1041)


   

3-(2-chlorophenyl)-N-({2-[(3-methyl-1H-pyrazol-5-yl)carbonyl]hydrazino}carbonothioyl)acrylamide

3-(2-chlorophenyl)-N-({2-[(3-methyl-1H-pyrazol-5-yl)carbonyl]hydrazino}carbonothioyl)acrylamide

C15H14ClN5O2S (363.0557)


   

5-bromo-N-[2-(4-methyl-1-piperazinyl)phenyl]-2-furancarboxamide

5-bromo-N-[2-(4-methyl-1-piperazinyl)phenyl]-2-furancarboxamide

C16H18BrN3O2 (363.0582)


   

4-chloro-N-(2-methoxy-1-phenazinyl)benzamide

4-chloro-N-(2-methoxy-1-phenazinyl)benzamide

C20H14ClN3O2 (363.0774)


   

Benzoic acid [2-oxo-2-[2-(phenylthio)anilino]ethyl] ester

Benzoic acid [2-oxo-2-[2-(phenylthio)anilino]ethyl] ester

C21H17NO3S (363.0929)


   

4-[2-[2-(4-Bromo-2-chlorophenoxy)ethoxy]ethyl]morpholine

4-[2-[2-(4-Bromo-2-chlorophenoxy)ethoxy]ethyl]morpholine

C14H19BrClNO3 (363.0237)


   

N-(4-methoxyphenyl)-N-thiophen-2-ylsulfonyl-2-furancarboxamide

N-(4-methoxyphenyl)-N-thiophen-2-ylsulfonyl-2-furancarboxamide

C16H13NO5S2 (363.0235)


   

N-(3,4-dimethoxyphenyl)-6-phenyl-4-thieno[2,3-d]pyrimidinamine

N-(3,4-dimethoxyphenyl)-6-phenyl-4-thieno[2,3-d]pyrimidinamine

C20H17N3O2S (363.1041)


   

5-Nitro-2-thiophenecarboxylic acid [2-oxo-2-[[oxo-[(phenylmethyl)amino]methyl]amino]ethyl] ester

5-Nitro-2-thiophenecarboxylic acid [2-oxo-2-[[oxo-[(phenylmethyl)amino]methyl]amino]ethyl] ester

C15H13N3O6S (363.0525)


   

4-[(2-Hydroxyanilino)methylidene]-2-(2-thiazolyl)isoquinoline-1,3-dione

4-[(2-Hydroxyanilino)methylidene]-2-(2-thiazolyl)isoquinoline-1,3-dione

C19H13N3O3S (363.0678)


   

7-[(3-hydroxy-3,4-dihydro-2H-benzo[h]quinolin-1-yl)methyl]-5-thiazolo[3,2-a]pyrimidinone

7-[(3-hydroxy-3,4-dihydro-2H-benzo[h]quinolin-1-yl)methyl]-5-thiazolo[3,2-a]pyrimidinone

C20H17N3O2S (363.1041)


   

2,5-Dimethoxybenzenesulfonic acid (1,3-dioxo-2-isoindolyl) ester

2,5-Dimethoxybenzenesulfonic acid (1,3-dioxo-2-isoindolyl) ester

C16H13NO7S (363.0413)


   

6-[[[1-(4-chlorophenyl)-5-tetrazolyl]thio]methyl]-N2,N2-dimethyl-1,3,5-triazine-2,4-diamine

6-[[[1-(4-chlorophenyl)-5-tetrazolyl]thio]methyl]-N2,N2-dimethyl-1,3,5-triazine-2,4-diamine

C13H14ClN9S (363.0781)


   

1-(4-Chlorophenyl)-5-[1-(2-oxolanylmethylamino)ethylidene]-1,3-diazinane-2,4,6-trione

1-(4-Chlorophenyl)-5-[1-(2-oxolanylmethylamino)ethylidene]-1,3-diazinane-2,4,6-trione

C17H18ClN3O4 (363.0986)


   

(1,2-Dimethyl-3-imidazo[1,2-a]pyridin-4-iumyl)-diphenyl-sulfanylidenephosphorane

(1,2-Dimethyl-3-imidazo[1,2-a]pyridin-4-iumyl)-diphenyl-sulfanylidenephosphorane

C21H20N2PS+ (363.1085)


   

3-[[4-(1,3,4-Oxadiazol-2-yl)phenyl]methyl]-2lambda6-thia-3-azatricyclo[6.3.1.04,12]dodeca-1(11),4,6,8(12),9-pentaene 2,2-dioxide

3-[[4-(1,3,4-Oxadiazol-2-yl)phenyl]methyl]-2lambda6-thia-3-azatricyclo[6.3.1.04,12]dodeca-1(11),4,6,8(12),9-pentaene 2,2-dioxide

C19H13N3O3S (363.0678)


   

N(4)-acetylcytidine 5-phosphate

N(4)-acetylcytidine 5-phosphate

C11H14N3O9P-2 (363.0468)


   

2-thiophen-2-yl-N-[(E)-thiophen-3-ylmethylideneamino]quinoline-4-carboxamide

2-thiophen-2-yl-N-[(E)-thiophen-3-ylmethylideneamino]quinoline-4-carboxamide

C19H13N3OS2 (363.05)


   

2,4-Dimethyl-6-[(2,4,5-trifluorophenyl)methyl]-5-thieno[3,4]pyrrolo[1,3-d]pyridazinone

2,4-Dimethyl-6-[(2,4,5-trifluorophenyl)methyl]-5-thieno[3,4]pyrrolo[1,3-d]pyridazinone

C17H12F3N3OS (363.0653)


   

2,4,6-Tris(4-fluorophenyl)pyrylium

2,4,6-Tris(4-fluorophenyl)pyrylium

C23H14F3O+ (363.0997)


   

(4R)-2-[2-[(S)-amino-(4-hydroxyphenyl)methyl]-5-hydroxy-1,3-oxazol-4-yl]-5,5-dimethyl-4H-1,3-thiazole-4-carboxylic acid

(4R)-2-[2-[(S)-amino-(4-hydroxyphenyl)methyl]-5-hydroxy-1,3-oxazol-4-yl]-5,5-dimethyl-4H-1,3-thiazole-4-carboxylic acid

C16H17N3O5S (363.0889)


   

9-(4-Fluorophenyl)-2-(4-methoxyphenyl)purine-6-carboxamide

9-(4-Fluorophenyl)-2-(4-methoxyphenyl)purine-6-carboxamide

C19H14FN5O2 (363.1131)


   

2-N-[(1S)-1-(3,5-dichlorophenyl)ethyl]-2-N-methylpyrimido[4,5-d]pyrimidine-2,5,7-triamine

2-N-[(1S)-1-(3,5-dichlorophenyl)ethyl]-2-N-methylpyrimido[4,5-d]pyrimidine-2,5,7-triamine

C15H15Cl2N7 (363.0766)


   

Cefadroxil

Cefadroxil

C16H17N3O5S (363.0889)


J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01D - Other beta-lactam antibacterials > J01DB - First-generation cephalosporins A cephalosporin bearing methyl and (2R)-2-amino-2-(4-hydroxyphenyl)acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D002511 - Cephalosporins D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C254 - Anti-Infective Agent > C258 - Antibiotic > C260 - Beta-Lactam Antibiotic

   

Fosdenopterin

Fosdenopterin

C10H14N5O8P (363.058)


A - Alimentary tract and metabolism > A16 - Other alimentary tract and metabolism products > A16A - Other alimentary tract and metabolism products > A16AX - Various alimentary tract and metabolism products C78272 - Agent Affecting Nervous System

   

GUANOSINE-3-monophosphATE

GUANOSINE-3-monophosphATE

C10H14N5O8P (363.058)


   

8-Oxo-2-deoxy-guanosine-5-monophosphate

8-Oxo-2-deoxy-guanosine-5-monophosphate

C10H14N5O8P (363.058)


   

7,8-Didemethyl-8-hydroxy-5-deazariboflavin

7,8-Didemethyl-8-hydroxy-5-deazariboflavin

C16H17N3O7 (363.1066)


   

Reactive Red 31

Guanosine-2-monophosphate

C10H14N5O8P (363.058)


   

precursor Z hydrate

precursor Z hydrate

C10H14N5O8P (363.058)


A linear-fused organic heterotetracyclic compound consisting of a [1,3,2]dioxaphosphinane fused to a pyran ring which is in turn fused to a pteridine ring system. Molybdenum cofactor biosynthesis intermediate. Dehydrated derivative known as precursor Z.

   

Guanosine 3-monophosphate

Guanosine 3-monophosphate

C10H14N5O8P (363.058)


A guanosine 3-phosphate compound with a monophosphate group at the 3-position.

   
   

Guanosine 5’-phosphate

{[(2R,3S,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid

C10H14N5O8P (363.058)


Guanosine monophosphate. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=85-32-5 (retrieved 2024-06-26) (CAS RN: 85-32-5). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). 5'-Guanylic acid (5'-GMP) is involved in several metabolic disorders, including the AICA-ribosiduria pathway, adenosine deaminase deficiency, adenine phosphoribosyltransferase deficiency (aprt), and the 2-hydroxyglutric aciduria pathway. 5'-Guanylic acid (5'-GMP) is involved in several metabolic disorders, including the AICA-ribosiduria pathway, adenosine deaminase deficiency, adenine phosphoribosyltransferase deficiency (aprt), and the 2-hydroxyglutric aciduria pathway.

   

Guanosine 5'-phosphate

Guanosine 5'-phosphate

C10H14N5O8P (363.058)


Guanosine monophosphate. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=85-32-5 (retrieved 2024-07-01) (CAS RN: 85-32-5). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). 5'-Guanylic acid (5'-GMP) is involved in several metabolic disorders, including the AICA-ribosiduria pathway, adenosine deaminase deficiency, adenine phosphoribosyltransferase deficiency (aprt), and the 2-hydroxyglutric aciduria pathway. 5'-Guanylic acid (5'-GMP) is involved in several metabolic disorders, including the AICA-ribosiduria pathway, adenosine deaminase deficiency, adenine phosphoribosyltransferase deficiency (aprt), and the 2-hydroxyglutric aciduria pathway.

   

Tedatioxetine (hydrobromide)

Tedatioxetine (hydrobromide)

C18H22BrNS (363.0656)


Tedatioxetine (Lu AA24530) hydrobromide acts as a serotonin and norepinephrine (NE)-preferring triple reuptake inhibitor (TRI) and 5-HT2A, 5-HT2C, 5-HT3 and α1A-adrenergic receptor antagonist[1]. ,

   

[4-hydroxy-5-(6-hydroxy-2-imino-3h-purin-9-yl)-2-(hydroxymethyl)oxolan-3-yl]oxyphosphonic acid

[4-hydroxy-5-(6-hydroxy-2-imino-3h-purin-9-yl)-2-(hydroxymethyl)oxolan-3-yl]oxyphosphonic acid

C10H14N5O8P (363.058)


   

11-methoxy-12-methyl-5,7,17,19-tetraoxa-12-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁶,²⁰]tetracosa-1(13),2,4(8),9,14,16(20),21,23-octaene

11-methoxy-12-methyl-5,7,17,19-tetraoxa-12-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁶,²⁰]tetracosa-1(13),2,4(8),9,14,16(20),21,23-octaene

C21H17NO5 (363.1107)


   

n-{4-[(1s)-7-bromo-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]butyl}guanidine

n-{4-[(1s)-7-bromo-1h,2h,3h,4h,9h-pyrido[3,4-b]indol-1-yl]butyl}guanidine

C16H22BrN5 (363.1058)


   

(2r,5r,6r,6as)-5-(6-aminopurin-9-yl)-2-(carboxymethyl)-6-hydroxy-5h,6h,6ah-furo[3,2-b]furan-2-carboxylic acid

(2r,5r,6r,6as)-5-(6-aminopurin-9-yl)-2-(carboxymethyl)-6-hydroxy-5h,6h,6ah-furo[3,2-b]furan-2-carboxylic acid

C14H13N5O7 (363.0815)


   

n-{2-[11-(methylsulfanyl)-12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl]ethyl}ethanimidic acid

n-{2-[11-(methylsulfanyl)-12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl]ethyl}ethanimidic acid

C20H17N3O2S (363.1041)


   

9-(beta-D-Xylofuranosyl)guanine delta-5'-monophosphate

47349-49-5; [(2R,3R,4R,5R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl dihydrogen phosphate; [(2R,3R,4R,5R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl dihydrogen phosphate; 6H-Purin-6-one, 2-amino-1,9-dihydro-9-(5-O-phosphono-beta-D-xylofuranosyl)-; [(2R,3R,4R,5R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxy-2-tetrahydrofuranyl]methyl dihydrogen phosphate; [(2R,3R,4R,5R)-5-(2-amino-6-keto-3H-purin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl dihydrogen phosphate; [(2R,3R,4R,5R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

C10H14N5O8P (363.058)


{"Ingredient_id": "HBIN014069","Ingredient_name": "9-(beta-D-Xylofuranosyl)guanine delta-5'-monophosphate","Alias": "47349-49-5; [(2R,3R,4R,5R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methyl dihydrogen phosphate; [(2R,3R,4R,5R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl dihydrogen phosphate; 6H-Purin-6-one, 2-amino-1,9-dihydro-9-(5-O-phosphono-beta-D-xylofuranosyl)-; [(2R,3R,4R,5R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxy-2-tetrahydrofuranyl]methyl dihydrogen phosphate; [(2R,3R,4R,5R)-5-(2-amino-6-keto-3H-purin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl dihydrogen phosphate; [(2R,3R,4R,5R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate","Ingredient_formula": "C10H14N5O8P","Ingredient_Smile": "C1=NC2=C(N1C3C(C(C(O3)COP(=O)(O)O)O)O)N=C(NC2=O)N","Ingredient_weight": "363.22","OB_score": "13.26019773","CAS_id": "47349-49-5","SymMap_id": "SMIT13546","TCMID_id": "NA","TCMSP_id": "MOL012818","TCM_ID_id": "NA","PubChem_id": "135612767","DrugBank_id": "NA"}

   

2-{12-oxoindolo[2,1-b]quinazolin-6-ylidene}-1h-indol-3-one

2-{12-oxoindolo[2,1-b]quinazolin-6-ylidene}-1h-indol-3-one

C23H13N3O2 (363.1008)


   

[4-hydroxy-2-(6-hydroxy-2-imino-3h-purin-9-yl)-5-(hydroxymethyl)oxolan-3-yl]oxyphosphonic acid

[4-hydroxy-2-(6-hydroxy-2-imino-3h-purin-9-yl)-5-(hydroxymethyl)oxolan-3-yl]oxyphosphonic acid

C10H14N5O8P (363.058)


   

n-(2-{6-oxa-4-thia-9,19-diazapentacyclo[10.7.1.0³,⁷.0⁸,²⁰.0¹³,¹⁸]icosa-1,3(7),8,10,12(20),13,15,17-octaen-2-yl}ethyl)ethanimidic acid

n-(2-{6-oxa-4-thia-9,19-diazapentacyclo[10.7.1.0³,⁷.0⁸,²⁰.0¹³,¹⁸]icosa-1,3(7),8,10,12(20),13,15,17-octaen-2-yl}ethyl)ethanimidic acid

C20H17N3O2S (363.1041)


   

[(2r,3r,4r,5r)-4-hydroxy-2-(6-hydroxy-2-imino-3h-purin-9-yl)-5-(hydroxymethyl)oxolan-3-yl]oxyphosphonic acid

[(2r,3r,4r,5r)-4-hydroxy-2-(6-hydroxy-2-imino-3h-purin-9-yl)-5-(hydroxymethyl)oxolan-3-yl]oxyphosphonic acid

C10H14N5O8P (363.058)


   

(3s,6r)-5-hydroxy-3-(1h-indol-3-ylmethyl)-1,6-dimethyl-3,6-bis(methylsulfanyl)pyrazin-2-one

(3s,6r)-5-hydroxy-3-(1h-indol-3-ylmethyl)-1,6-dimethyl-3,6-bis(methylsulfanyl)pyrazin-2-one

C17H21N3O2S2 (363.1075)


   

12-methoxy-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaene

12-methoxy-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaene

C21H17NO5 (363.1107)


   

5-hydroxy-3-(1h-indol-3-ylmethyl)-1,6-dimethyl-3,6-bis(methylsulfanyl)pyrazin-2-one

5-hydroxy-3-(1h-indol-3-ylmethyl)-1,6-dimethyl-3,6-bis(methylsulfanyl)pyrazin-2-one

C17H21N3O2S2 (363.1075)


   

(6r,7r)-7-{[(2r)-2-amino-1-hydroxy-2-(4-hydroxyphenyl)ethylidene]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6r,7r)-7-{[(2r)-2-amino-1-hydroxy-2-(4-hydroxyphenyl)ethylidene]amino}-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C16H17N3O5S (363.0889)


   

[(23r)-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-yl]methanol

[(23r)-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-yl]methanol

C21H17NO5 (363.1107)


   

15,17-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2(10),3,8,11,14(19),15,17-octaen-20-one

15,17-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2(10),3,8,11,14(19),15,17-octaen-20-one

C21H17NO5 (363.1107)


   

6-(4-hydroxybenzoyl)-5-(4-hydroxyphenyl)-7h-pyrrolo[2,3-d]pyrimidine-2,4-diol

6-(4-hydroxybenzoyl)-5-(4-hydroxyphenyl)-7h-pyrrolo[2,3-d]pyrimidine-2,4-diol

C19H13N3O5 (363.0855)


   

(2r,5s,6r,6ar)-5-(6-aminopurin-9-yl)-2-(carboxymethyl)-6-hydroxy-5h,6h,6ah-furo[3,2-b]furan-2-carboxylic acid

(2r,5s,6r,6ar)-5-(6-aminopurin-9-yl)-2-(carboxymethyl)-6-hydroxy-5h,6h,6ah-furo[3,2-b]furan-2-carboxylic acid

C14H13N5O7 (363.0815)


   

15,16,17-trimethoxy-11-azapentacyclo[9.6.2.0²,⁷.0⁸,¹⁹.0¹⁴,¹⁸]nonadeca-1(18),2(7),3,5,8(19),14,16-heptaene-9,10-dione

15,16,17-trimethoxy-11-azapentacyclo[9.6.2.0²,⁷.0⁸,¹⁹.0¹⁴,¹⁸]nonadeca-1(18),2(7),3,5,8(19),14,16-heptaene-9,10-dione

C21H17NO5 (363.1107)


   

4,8-dihydroxy-10-[(2s,3s,4r)-2,3,4,5-tetrahydroxypentyl]pyrimido[4,5-b]quinolin-2-one

4,8-dihydroxy-10-[(2s,3s,4r)-2,3,4,5-tetrahydroxypentyl]pyrimido[4,5-b]quinolin-2-one

C16H17N3O7 (363.1066)


   

(23s)-23-methoxy-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaene

(23s)-23-methoxy-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaene

C21H17NO5 (363.1107)


   

n-{2-[16-(methylsulfanyl)-12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl]ethyl}ethanimidic acid

n-{2-[16-(methylsulfanyl)-12-oxo-8,14-diazatetracyclo[7.7.1.0²,⁷.0¹³,¹⁷]heptadeca-1(17),2(7),3,5,8,10,13,15-octaen-10-yl]ethyl}ethanimidic acid

C20H17N3O2S (363.1041)


   

16,17,20-trimethoxy-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2(10),3,8,11,14(19),15,17,20-nonaene

16,17,20-trimethoxy-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2(10),3,8,11,14(19),15,17,20-nonaene

C21H17NO5 (363.1107)


   

23-methoxy-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaene

23-methoxy-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21)-octaene

C21H17NO5 (363.1107)


   

4,8-dihydroxy-10-[(2s,3s,4s)-2,3,4,5-tetrahydroxypentyl]pyrimido[4,5-b]quinolin-2-one

4,8-dihydroxy-10-[(2s,3s,4s)-2,3,4,5-tetrahydroxypentyl]pyrimido[4,5-b]quinolin-2-one

C16H17N3O7 (363.1066)


   

[(2r,3s,4r,5r)-3,4-dihydroxy-5-(6-hydroxy-2-imino-3h-purin-9-yl)oxolan-2-yl]methoxyphosphonic acid

[(2r,3s,4r,5r)-3,4-dihydroxy-5-(6-hydroxy-2-imino-3h-purin-9-yl)oxolan-2-yl]methoxyphosphonic acid

C10H14N5O8P (363.058)


   

2-[(6e)-12-oxoindolo[2,1-b]quinazolin-6-ylidene]-1h-indol-3-one

2-[(6e)-12-oxoindolo[2,1-b]quinazolin-6-ylidene]-1h-indol-3-one

C23H13N3O2 (363.1008)


   

5-(6-aminopurin-9-yl)-2-(carboxymethyl)-6-hydroxy-5h,6h,6ah-furo[3,2-b]furan-2-carboxylic acid

5-(6-aminopurin-9-yl)-2-(carboxymethyl)-6-hydroxy-5h,6h,6ah-furo[3,2-b]furan-2-carboxylic acid

C14H13N5O7 (363.0815)


   

[(2r,3s,4r,5s)-3,4-dihydroxy-5-(6-hydroxy-2-imino-3h-purin-9-yl)oxolan-2-yl]methoxyphosphonic acid

[(2r,3s,4r,5s)-3,4-dihydroxy-5-(6-hydroxy-2-imino-3h-purin-9-yl)oxolan-2-yl]methoxyphosphonic acid

C10H14N5O8P (363.058)


   

{24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-yl}methanol

{24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaen-23-yl}methanol

C21H17NO5 (363.1107)


   

2-[(6z)-12-oxoindolo[2,1-b]quinazolin-6-ylidene]-1h-indol-3-one

2-[(6z)-12-oxoindolo[2,1-b]quinazolin-6-ylidene]-1h-indol-3-one

C23H13N3O2 (363.1008)


   

[(z)-(3-hydroxy-1-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene)amino]oxysulfonic acid

[(z)-(3-hydroxy-1-{[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}propylidene)amino]oxysulfonic acid

C9H17NO10S2 (363.0294)


   

(19r)-19-methoxy-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaene

(19r)-19-methoxy-24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,11,14,16,21-octaene

C21H17NO5 (363.1107)


   

16,17-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2(10),3,8,11,14(19),15,17-octaen-20-one

16,17-dimethoxy-21-methyl-5,7-dioxa-21-azapentacyclo[11.8.0.0²,¹⁰.0⁴,⁸.0¹⁴,¹⁹]henicosa-1(13),2(10),3,8,11,14(19),15,17-octaen-20-one

C21H17NO5 (363.1107)


   

2,4-dihydroxy-10-(2,3,4,5-tetrahydroxypentyl)pyrimido[4,5-b]quinolin-8-one

2,4-dihydroxy-10-(2,3,4,5-tetrahydroxypentyl)pyrimido[4,5-b]quinolin-8-one

C16H17N3O7 (363.1066)